Investor FAQ

Echo is revolutionizing the quantified self.

We see a tremendous opportunty to deliver technology that will empower millions of people around the world to take better care of themselves and create a healthier world.

General

When did Echo go public?

Echo became a public company on September 14, 2007 as a result of the merger of Sontra Medical Corporation (OTC BB: SONT) and then privately held Echo Therapeutics, Inc. (ETI). Following the merger, Sontra changed its name to Echo Therapeutics, Inc. on October 8, 2007 and began trading on the OTC BB under the stock symbol ECTE. On June 29, 2011, Echo began trading on the NASDAQ Capital Market. On July 12, 2016, Echo began trading on the OTCQB Venture Market, operated by OTC Market Groups, Inc.

On what exchange does Echo trade and what is its ticker symbol?

Effective July 12, 2016, Echo is traded on the OTCQB Venture Market under the stock symbol “ECTE.”

How can I invest in Echo? Can I purchase Echo stock directly from the company?

The company does not have a direct stock purchase plan. Shares of Echo common stock may be bought through a broker or stock purchase service of your choice.

Who is your transfer agent and how do I contact them?

Manhattan Transfer Registrar Company
531 Cardens Court
Erie, CO 80516

(877) 645-8691

When do I receive my certificate of ownership?

Please contact Echo’s transfer agent with questions about your stock certificates.

What is Echo's policy on dividends?

To date, Echo has not paid cash dividends. The company expects to retain future earnings to fund the development and growth of the business and does not anticipate declaring or paying cash dividends in the foreseeable future.

When and where is the Echo Annual Stockholders' Meeting?

The Echo Annual Stockholders’ Meeting is expected to be held on or before December 31, 2015

How do I contact Investor Relations?

You may contact Christine Olimpio, Telephone: (732) 549-0128 or email: colimpio@echotx.com

Corporate Governance Information

Where can I get information on Echo's Corporate Governance practices?

Please visit the following section of our website to read our corporate governance guidelines. For additional questions regarding corporate governance at Echo, please contact: inquiries@echotx.com. Please use this e-mail for legitimate business inquiries. Solicitations of any kind will be ignored.

How can I contact Echo's Board of Directors?

You may contact our Board of Directors via email: boardofdirectors@echotx.com. Please use this e-mail to contact the Board of Directors for legitimate business inquiries. You may also send written communications for the Board to the attention of the Secretary, Echo Therapeutics, Inc., 99 Wood Avenue South, Suite 302, Iselin, NJ 08830.  Any such communication should clearly indicate that it is intended for the Board of Directors and any communication intended for a particular Board member or committee should clearly state the intended recipient.  All such communications will be relayed accordingly, except for mass mailings, job inquiries, surveys, business solicitations or advertisements, or patently offensive or otherwise inappropriate material.

How many members of Echo's board of directors are independent under SEC standards?

The Board of Directors has determined that each of Messrs. Michael M. Goldberg, M.D., Shepard Goldberg and Elazer Edelman, M.D., Ph.D., constituting three of the directors of the Company, satisfies the criteria for being an “independent director” under the standards of the Nasdaq Stock Market, Inc. (“Nasdaq”) and has no material relationship with the Company other than by virtue of service on the Board of Directors.

Corporate Information

Where is Echo's headquarters located?

Echo Headquarters / Mailing address:
Echo Therapeutics, Inc.
99 Wood Avenue South
Suite 302
Iselin, NJ 08830 USA
Telephone: (732) 549-0128

When was Echo founded?

Sontra Medical, the predecessor to Echo Therapeutics, was founded in 1998.

Where is Echo incorporated?

Echo Therapeutics, Inc. is a Delaware corporation.